Several novel therapies are now present in the Britain for managing type 2 diabetes . copyright , Rybelsus , and Mounjaro represent distinct approaches, with Saxenda and Jardiance being injectable peptide receptor agonists primarily aimed at weight management alongside glucose stabilization, whil